FDA Inspection
Cohance Lifesciences LimitedCohance Lifesciences Limited – FDA Inspection, Feb 15, 2018
Record Details
This FDA Inspection record concerns Cohance Lifesciences Limited, with an inspection on February 15, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c3fdedea-4c22-4b83-a805-2135836e7f2e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1041216
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cohance Lifesciences Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 5, 2026 | Not classified | Office of Inspections and Investigations | |
| February 23, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 14, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 8, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cohance Lifesciences Limited
- FDA Inspection 1335432 - 2026-08-05
- FDA Inspection 1234405 - 2024-02-23
- FDA Inspection 1110488 - 2019-11-01
- FDA Inspection 973825 - 2016-04-14
- FDA Inspection 854615 - 2013-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.